Use of Updated Census First-Name and Surname Data to Improve Race and Ethnicity Imputation - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Improving Race and Ethnicity Imputation With Updated Census First- and Last-Name Data

  • By

  • Steven C. Martino

  • Anthony J. Sisti

  • Zach Dietrich

  • Ann Haas

  • R. Mitchell Thomas

  • Mark W. Friedberg

  • Marc N. Elliott

  • November 20, 2026

Share

Clinical Scorecard: Improving Race and Ethnicity Imputation With Updated Census First- and Last-Name Data

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Improving Race and Ethnicity Imputation With Updated Census First- and Last-Name Data
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationBCBSMA members enrolled in commercial or Medicare plans during 2025 who had survey-reported race and ethnicity in one of the four analyzed groups: Asian American and Pacific Islander, Black, Hispanic, or White.
Care SettingCare setting described in the source article.

Key Highlights

  • The cross-sectional analysis included 771,215 insured survey respondents; the four analyzed groups represented 96.0% of self-reporters.
  • mBIFSG 2.0 updated first-name and surname inputs with 2020 Census data; the 2020 Census block-group component was unchanged from mBIFSG 1.0.
  • Compared with mBIFSG 1.0, C-statistics increased by 0.9 to 1.8 points across the four analyzed groups.
  • Improvements were generally greater among female than male respondents, although C-statistics remained somewhat higher for male respondents in three groups.
  • The authors state that mBIFSG probabilities are intended for population-level assessment, not for determining an individual’s race or ethnicity.

Guideline-Based Recommendations

Diagnosis

    Management

    • The study compared mBIFSG 2.0 with mBIFSG 1.0 against survey-reported race and ethnicity; the supplied excerpt notes potential use of more accurate imputation for quality measurement and intervention targeting.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        The analytic cohort comprised 771,215 BCBSMA commercial or Medicare members enrolled in 2025 who had survey-reported race and ethnicity in one of four analyzed groups.

        Not applicable; this study evaluated an imputation method rather than a treatment. mBIFSG 2.0 showed higher concordance with self-report than mBIFSG 1.0 across all four analyzed groups.

        Clinical Best Practices

          Related Resources & Content

          Original Source(s)

          Related Content